These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9129188)

  • 1. Evidence for independent hypertensive effects of oxytocin and vasopressin in the rat dorsal vagal complex.
    Tian PS; Ingram CD
    Neurosci Res; 1997 Mar; 27(3):285-8. PubMed ID: 9129188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arg8]vasotocin excites neurones in the dorsal vagal complex in vitro: evidence for an action through novel class(es) of CNS receptors.
    Ingram CD; Tolchard S
    J Neuroendocrinol; 1994 Aug; 6(4):415-22. PubMed ID: 7987372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptors for neurohypophyseal hormones along the rat nephron: 125I-labelled d(CH2)5[Tyr(Me)2, Thr4, Orn8, Tyr-NH(2)9] vasotocin binding in microdissected tubules.
    Ammar A; Schmidt A; Semmekrot B; Roseau S; Butlen D
    Pflugers Arch; 1991 Apr; 418(3):220-7. PubMed ID: 1830390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oxytocin receptor antagonists on the renal actions of oxytocin and vasopressin in the rat.
    Windle RJ; Judah JM; Forsling ML
    J Endocrinol; 1997 Feb; 152(2):257-64. PubMed ID: 9071983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of oxytocin antagonists, which are more selective than atosiban.
    Manning M; Stoev S; Cheng LL; Wo NC; Chan WY
    J Pept Sci; 2001 Sep; 7(9):449-65. PubMed ID: 11587184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. V2-like vasopressin receptor mobilizes intracellular Ca2+ in rat medullary collecting tubules.
    Champigneulle A; Siga E; Vassent G; Imbert-Teboul M
    Am J Physiol; 1993 Jul; 265(1 Pt 2):F35-45. PubMed ID: 8342613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of [Arg8]vasopressin and [Arg8]vasotocin on the firing rate of suprachiasmatic neurons in vitro.
    Mihai R; Coculescu M; Wakerley JB; Ingram CD
    Neuroscience; 1994 Oct; 62(3):783-92. PubMed ID: 7870306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of V1a vasopressin receptors in the rat cortical collecting duct.
    Ammar A; Roseau S; Butlen D
    Am J Physiol; 1992 Apr; 262(4 Pt 2):F546-53. PubMed ID: 1533099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin.
    Manning M; Kruszynski M; Bankowski K; Olma A; Lammek B; Cheng LL; Klis WA; Seto J; Haldar J; Sawyer WH
    J Med Chem; 1989 Feb; 32(2):382-91. PubMed ID: 2913298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of neurohypophyseal antagonists in postnephrectomy natriuresis in male rats.
    Huang W; Lee SL; Sjöquist M
    Kidney Int; 1994 Mar; 45(3):692-9. PubMed ID: 8196272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxytocin antagonist blocks the vasodepressor but not the vasopressor effect of neurohypophysial peptides in chickens.
    Robinzon B; Koike TI; Marks PA
    Peptides; 1994; 15(8):1407-13. PubMed ID: 7700844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isosteric substitution of Asn5 in antagonists of oxytocin and vasopressin leads to highly selective and potent oxytocin and V1a receptor antagonists: new approaches for the design of potential tocolytics for preterm labor.
    Chan WY; Wo NC; Cheng LL; Manning M
    J Pharmacol Exp Ther; 1996 May; 277(2):999-1003. PubMed ID: 8627583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin and oxytocin receptors on plasma membranes from rat mammary gland. Demonstration of vasopressin receptors by stimulation of inositol phosphate formation, and oxytocin receptors by binding of a specific 125I-labeled oxytocin antagonist, d(CH2)5(1)[Tyr(Me)2, Thr4,Tyr-NH2(9)]OVT.
    Soloff MS; Fernström MA; Fernström MJ
    Biochem Cell Biol; 1989; 67(2-3):152-62. PubMed ID: 2546575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frog glomerular vasotocin receptors resemble mammalian V1b receptors.
    Ammar A; Rajerison RM; Roseau S; Bloch-Faure M; Butlen D
    Am J Physiol; 1994 Nov; 267(5 Pt 2):R1198-208. PubMed ID: 7977846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a single administration of oxytocin or vasopressin and their interactions with two selective receptor antagonists on memory storage in mice.
    Boccia MM; Kopf SR; Baratti CM
    Neurobiol Learn Mem; 1998 Mar; 69(2):136-46. PubMed ID: 9619993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting oxytocin antagonists: effects of 2-D-stereoisomer substitution on antagonistic potency and duration of action.
    Chan WY; Rockway TW; Hruby VJ
    Proc Soc Exp Biol Med; 1987 Jun; 185(2):187-92. PubMed ID: 3575333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual actions of vasopressin and oxytocin in regulation of water permeability in terminal collecting duct.
    Han JS; Maeda Y; Knepper MA
    Am J Physiol; 1993 Jul; 265(1 Pt 2):F26-34. PubMed ID: 8393623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged stimulation of intrarenal V1 vasopressin receptors results in sustained hypertension.
    Szczepanska-Sadowska E; Stepniakowski K; Skelton MM; Cowley AW
    Am J Physiol; 1994 Nov; 267(5 Pt 2):R1217-25. PubMed ID: 7977848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of the biological effects of neurohypophysial peptides on seminiferous tubules.
    Harris GC; Nicholson HD
    J Endocrinol; 1998 Jan; 156(1):35-42. PubMed ID: 9496231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a D-Cys6/L-Cys6 interchange in nonselective and selective vasopressin and oxytocin antagonists.
    Manning M; Cheng LL; Klis WA; Balaspiri L; Olma A; Sawyer WH; Wo NC; Chan WY
    J Med Chem; 1995 May; 38(10):1762-9. PubMed ID: 7752199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.